Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Prothena Corporation plc - Ordinary Shares
(NQ:
PRTA
)
6.180
+0.190 (+3.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Prothena Corporation plc - Ordinary Shares
< Previous
1
2
3
4
5
6
7
Next >
8 Analysts Assess Prothena Corp: What You Need To Know
June 20, 2025
Via
Benzinga
Prothena Shares Get A Boost After Company Slashes Workforce, Lowers 2025 Cash Burn Forecast
June 20, 2025
The biotech firm expects to end 2025 with nearly $300 million in cash as it pivots to focus on its Alzheimer’s and Parkinson’s pipeline.
Via
Stocktwits
Topics
Workforce
Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday
May 28, 2025
Via
Benzinga
Here are the top movers in Tuesday's session.
May 27, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via
Chartmill
Earnings Scheduled For May 8, 2025
May 08, 2025
Via
Benzinga
A Look Ahead: Prothena Corp's Earnings Forecast
May 07, 2025
Via
Benzinga
Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
February 24, 2025
Via
Benzinga
Earnings Scheduled For February 20, 2025
February 20, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 27, 2025
Via
Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
May 27, 2025
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
May 27, 2025
In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.
Via
Chartmill
Deep Dive Into Prothena Corp Stock: Analyst Perspectives (5 Ratings)
February 07, 2025
Via
Benzinga
Demystifying Prothena Corp: Insights From 6 Analyst Reviews
December 20, 2024
Via
Benzinga
PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday
May 27, 2025
Via
Benzinga
Expert Outlook: Prothena Corp Through The Eyes Of 5 Analysts
May 27, 2025
Via
Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
May 27, 2025
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
May 27, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 27, 2025
Via
Benzinga
Why Is Prothena Stock Trading Lower On Tuesday?
May 27, 2025
Prothena halts birtamimab development after Phase 3 trial fails to meet endpoints in AL amyloidosis patients; cost cuts and new focus expected.
Via
Benzinga
US Stocks Likely To Open Higher After S&P 500's Four-Day Fall: 'Market Is Risk-Off,' Says Expert
May 27, 2025
U.S. stock futures rose on Tuesday after closing lower for the week on Friday. Futures of benchmark indices were trading higher in premarket.
Via
Benzinga
Topics
Stocks
Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
May 27, 2025
Via
Benzinga
These stocks are moving in today's after hours session
May 26, 2025
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
May 23, 2025
Via
Benzinga
Top movers in Friday's after hours session
May 23, 2025
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
May 16, 2025
Via
Benzinga
Beyond The Numbers: 7 Analysts Discuss Prothena Corp Stock
May 09, 2025
Via
Benzinga
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter
May 09, 2025
Via
Benzinga
CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
February 26, 2025
Via
Benzinga
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
January 28, 2025
Via
Benzinga
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
December 20, 2024
Via
Benzinga
Topics
Stocks
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.